- $1.05bn
- $2.33bn
- $289.20m
- 73
- 93
- 72
- 94
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 22 | 89 | 84.3 | 139 | 70.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 50.5 | 69 | 253 | 62.7 | 52.9 |
Prepaid Expenses | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Other Assets | |||||
Total Assets | 1,253 | 1,677 | 2,161 | 2,710 | 2,677 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 682 | 959 | 1,419 | 1,518 | 1,481 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 571 | 718 | 742 | 1,192 | 1,197 |
Total Liabilities & Shareholders' Equity | 1,253 | 1,677 | 2,161 | 2,710 | 2,677 |
Total Common Shares Outstanding |